Application of infrared spectroscopy in the study of neurological diseases

Biomedical Spectroscopy and Imaging

Volumn 1, Issue 4, 2012, Pages 303-323

  Turker, Sevgi ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Alzheimer s disease; Diagnosis; Epilepsy; FTIR; FTIRM; Multiple sclerosis; Parkinson s disease; Protein secondary structure; Transmissible spongiform encephalopathies

Indexed keywords

EID: 85013588996     PISSN: 22128794     EISSN: 22128808     Source Type: Journal    
DOI: 10.3233/BSI-120023     Document Type: Review

References (144)

1. J.A. Aarli, T. Dua, A. Janca and A. Muscetta, Neurological Disorders: Public Health Challenges, World Health Organization Press, Geneva, 2006.
2. A. Aguzzi and A. Calella, Prions: protein aggregation and infectious diseases, Physiol. Rev. 89 (2009), 1105-1152.
3. B. Akkas, S. Inci, F. Zorlu and F. Severcan, Melatonin affects the order, dynamics and hydration of brain membrane lipids, J. Mol. Struct. 6 (2007), 834-836.
4. S.B. Akkas, M. Severcan, O. Yilmaz and F. Severcan, Effects of lipoic acid supplementation on rat brain tissue: an FTIR spectroscopic and neural network study, Food Chem. 105 (2007), 1281-1288.
5. M. Banyay, M. Sarkar and A. Graslund, A library of IR bands of nucleic acids in solution, Biophys. Chem. 104 (2003), 477-488.
6. S. Barghorn, P. Davies and E. Mandelkow, Tau paired helical filaments from Alzheimer’s disease brain and assembled in vitro are based on beta-structure in the core domain, Biochemistry 43 (2004), 1694-703.
7. M.H. Barnett, A.P.D. Henderson and J.W. Prineas, The macrophage in MS: just a scavenger after all Pathology and pathogenesis of the acute MS lesion, Mult. Scler. 12 (2006), 121-132.
8. M.H. Barnett and J.W. Prineas, Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion, Ann. Neurol. 55 (2004), 458-468.
9. C.J. Barrow, A. Yasuda, P.T. Kenny and M.G. Zagorski, Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer’s disease. Analysis of circular dichroism spectra, J. Mol. Biol. 225 (1992), 1075-1093.
10. P. Bassan, A. Kohler, H. Martens, J. Lee, H.J. Byrne, P. Dumas, E. Gazi, M. Brown, N.W. Clarke and P. Gardner, Resonant Mie Scattering (RMieS) correction of infrared spectra from highly scattering biological samples, Analyst 135 (2010), 268-277.
11. M. Beekes, P. Lasch and D. Naumann, Analytical applications of Fourier transform-infrared (FT-IR) spectroscopy in microbiology and prion research, Vet. Microbiol. 123 (2007), 305-319.
12. J.L. Bennett and O. Stuve, Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications, Clin. Neuropharmacol. 32 (2009), 121-132.
13. A. Boskey, R. Mendelsohn, Infrared analysis of bone in health and disease, J. Biomed. Opt. 10 (2005), 031102.
14. O. Bozkurt, M. Severcan and F. Severcan, Diabetes induces compositional, structural and functional alterations on rat skeletal muscles revealed by FTIR spectroscopy: a comparative study with EDL muscle, Analyst 135 (2010), 3110-3119.
15. P.S. Bromberg, K.M. Gough, M. Ogg, M.R. del Bigio and R. Julian, Synchrotron FTIR microspectroscopy of Alzheimer’s diseased brain tissue at the SRC beamline, Proc. SPIE 3775 (1999), 118-126.
16. D.M. Byler and H. Susi, Examination of the secondary structure of proteins by deconvolved FTIR spectra, Biopolymers 25 (1986), 469-487.
17. S. Cai and B.R. Singh, A distinct utility of the amide III infrared band for secondary structure estimation of aqueous protein solutions using partial least squares methods, Biochemistry 43 (2004), 2451-2459.
18. G. Cakmak, L.M. Miller, F. Zorlu and F. Severcan, Amifostine, a radioprotectant agent, protects rat brain tissue lipids againstionizing radiation induced damage: an FTIR microspectroscopic imaging study, Arch. Biochem. Biophys. 520 (2012), 67-73.
19. G. Cakmak, I. Togan and F. Severcan, 17 beta-estradiol induced compositional, structural and functional changes in rainbow trout liver, revealed by FT-IR spectroscopy: a comparative study with nonylphenol, Aquat. Toxicol. 77 (2006), 53-63.
20. G. Cakmak, F. Zorlu, M. Severcan and F. Severcan, Screening of protective effect of amifostine on radiation-induced structural and functional variations in rat liver microsomal membranes by FTIR spectroscopy, Anal. Chem. 83 (2011), 2438-2444.
21. N.P. Camacho, P. West, P.A. Torzilli and R. Mendelsohn, FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage, Biopolymers 62 (2001), 1.
22. P. Carmona, M. Molina, M. Calero, F. Bermejo-Pareja, P. Martínez-Martín, I. Alvarez and A. Toledano, Infrared spectroscopic analysis of mononuclear leukocytes in peripheral blood from Alzheimer’s disease patients, Anal. Bioanal. Chem. 402 (2012), 2015-2021.
23. B. Caughey, G.J. Raymond and R.A. Bessen, Strain-dependent differences in beta sheet conformations of abnormal prion protein, J. Biol. Chem. 273 (1998), 32230-32235.
24. B.W. Caughey, A. Dong, K.S. Bhat, D. Ernst, S.F. Hayes and W.S. Caughey, Secondary structure analysis of the scrapieassociated protein PrP 27-30 in water by infrared spectroscopy, Biochemistry 30 (1991), 7672-7680.
25. L. Chiriboga, H. Yee and M. Diem, Infrared spectroscopy of human cells and tissues. Part VII. FT-IR Microspectroscopy of DNAase- and RNAase-treated normal, cirrhotic, and neoplastic liver tissue, Appl. Spectrosc. 54 (2000), 480-485.
26. L Choo, J.R. Mansfield, N. Pizzi, R.L. Somorjai, M. Jackson, W.C. Halliday and H.H. Mantsch, Infrared spectra of human central nervous system tissue: diagnosis of Alzheimer’s disease by multivariate analyses, Biospectroscopy 1 (1995), 141-148.
27. L.P. Choo, M. Jackson, W.C. Halliday and H.H. Mantsch, Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system, Biochim. Biophys. Acta 1182 (1993), 333-337.
28. L.P. Choo, D.L. Wetzel, W.C. Halliday, M. Jackson, S.M. LeVine and H.H. Mantsch, In situ characterization of betaamyloid in Alzheimer’s diseased tissue by synchrotron Fourier transform infrared microspectroscopy, Biophys. J. 71 (1996), 1672-1679.
29. J. Chwiej, J. Dulinska, K. Janeczko, P. Dumas, D. Eichert, J. Dudala and Z. Setkowicz, Synchrotron FTIR microspectroscopy study of the rat hippocampal formation after pilocarpine-evoked seizures, J. Chem. Neuroanat. 40 (2010), 140-147.
30. O.C. Cockerell, A.L. Johnson and S.D. Shorvon, Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study, Epilepsia 38 (1997), 31-46.
31. P. Colarusso, L.H. Kidder, I.W. Levin, J.C. Fraser, J.F. Arens and E.N. Lewis, Infrared spectroscopic imaging: from planetary to cellular systems, Appl. Spectrosc. 52 (1998), 106A-120A.
32. C.S. Colley, S.G. Kazarian, P.D. Weinberg and M.J. Lever, Spectroscopic imaging of arteries and atherosclerotic plaques, Biopolymers 74 (2004), 328-335.
33. S.J. Collins, V.A. Lawson and C.L. Masters, Transmissible spongiform encephalopathies, Lancet 363 (2004), 51-61.
34. K.A. Conway, J.D. Harper and P.T. Lansbury, Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid, Biochemistry 39 (2000), 2552-2563.
35. K.D. Coon, T. Dunckley and D.A. Stephan, Review: Biomarker identification in neurologic diseases: improving diagnostics and therapeutics, Expert Rev. Mol. Diagn. 4 (2004), 361-375.
36. P. Cortelli, D. Perani, P. Parchi, F. Grassi, P. Montagna, M.D. Martin, R. Castellani, P. Tinuper, P. Gambetti, E. Lugaresi and F. Fazio, Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein, Neurology 49 (1997), 126-133.
37. B.J. Davis, P.S. Carney and R. Bhargava, Theory of mid-infrared absorption microspectroscopy: II. Heterogeneous samples, Anal. Chem. 82 (2010), 3487-3499.
38. R.J. De Lorenzo, D.A. Sun and L.S. Deshpande, Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy, Pharmacol. Ther. 105 (2005), 229-266.
39. D.P. De Sousa, J. Gocalves and L. Quintans, Study of anticonvulsant effect of citronellol, a monoterpene alcohol, in rodents, Neurosci. Lett. 401 (2006), 231-235.
40. T.C. Dickson and J.C. Vickers, The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease, Neuroscience 105 (2001), 99-107.
41. M. Diem, M.S. Boydston-White and L. Chiriboga, IR spectroscopy of cells and tissues: shining light onto an unsettled subject, Appl. Spectrosc. 53 (1999), 148A.
42. M. Diem, L. Chiriboga, P. Lasch and A. Pacifico, IR spectra and IR spectral maps of individual normal and cancerous cells, Biopolymers 67 (2002), 349.
43. M. Diem, P.R. Griffiths and J.M. Chalmers, Vibrational Spectroscopy for Medical Diagnosis, Wiley, Chichester, 2008.
44. M. Diem, M. Romeo, L. Miller and P. Lasch, Comparison of Fourier transform infrared (FTIR) spectra of individual cells acquired using synchrotron and conventional sources, Infrared Phys. Technol. 45 (2004), 118-331.
45. J. Dulinska, Z. Setkowicz, K. Janeczko, C. Sandt, P. Dumas, L. Uram, K. Gzielo-Jurek and J. Chwiej, Synchrotron radiation Fourier-transform infrared and Raman microspectroscopy study showing an increased frequency of creatine inclusions in the rat hippocampal formation following pilocarpine-induced seizures, Anal. Bioanal. Chem. 402 (2012), 2267-2274.
46. P. Dumas, Microanalysis and imaging capabilities of synchrotron infrared microscopy, J. Phys. IV France 104 (2003), 359-364.
47. P. Dumas and L. Miller, The use of synchrotron infrared microspectroscopy in biological and biomedical investigations, Vib. Spectrosc. 32 (2003), 21.
48. H Fabian, L.P. Choo, G.I. Szendrei, M. Jackson, W.C. Halliday and H.H. Mantsch, Infrared spectroscopic characterization of Alzheimer plaques, Appl. Spectrosc. 47 (1993), 1513-1518.
49. D.C. Fernandez, R. Bhargava, S.M. Hewitt and I.W. Levin, Infrared spectroscopic imaging for histopathologic recognition, Nat. Biotechnol. 23 (2005), 469-474.
50. M. Gallant, M. Rak, A. Szeghalmi, M.R. Del Bigio, D. Westaway, J. Yang, R. Julian and K.M. Gough, Focally elevated creatine detected in amyloid precursor protein (APP) transgenic mice and Alzheimer’s disease brain tissue, J. Biol. Chem. 281 (2006), 5-8.
51. S. Garip, E. Yapici, N. Ozek, M. Severcan and F. Severcan, Evaluation and discrimination of simvastatin-induced structural alterations in proteins of different rat tissues by FTIR spectroscopy and neural network analysis, Analyst 135 (2010), 3233-3241.
52. D. Gasper, J. Dewelle and R. Kiss, IR spectroscopy as a new tool for evidencing antitumor drug signatures, Biochim. Biophys. Acta 1788 (2009), 1263-1270.
53. S.T. Gorgulu, N. Ates, G. Ilbay, Z. Gunes, N. Kara and F. Severcan, An FTIR approach to investigate molecular changes induced by epilepsy, WSEAS Trans. Biol. Biomed. 2 (2005), 355-358.
54. S.T. Gorgulu, N. Kara, Z. Gunes, N. Ates, G. Ilbay and F. Severcan, The investigation of early molecular consequences of chemically induced epileptic activity, Epilepsia 47 (2006), 234-235.
55. K. Gough, M. Rak, A. Bookatz, M. Del Bigio, S. Mai and D. Westaway, Choices for tissue visualization with IR microspectroscopy, Vib. Spectrosc. 38 (2005), 133-141.
56. 1 suppression, Anal. Biochem. 316 (2003), 232-234.
57. M. Griebe, M. Daffertshofer, M. Stroick, M. Syren, P. Ahmad-Nejad, M. Neumaier, J. Backhaus, M.G. Hennerici and M. Fatar, Infrared spectroscopy: a new diagnostic tool in Alzheimer disease, Neurosci. Lett. 420 (2007), 29-33.
58. P. Griffiths and J.A. De Haseth, Fourier Transform Infrared Spectrometry, Wiley-Interscience, New York, 2007.
59. M.J. Hackett, R. Siegele, F. El-Assaad, J.A. McQuillan, J.B. Aitken, E.A. Carter, G.E. Grau, N.H. Hunt, D. Cohen and P.A. Lay, Investigation of the mouse cerebellum using STIM and l-PIXE spectrometric and FTIR spectroscopic mapping and imaging, Lay Nuclear Instr. Methods Phys. Res. B 269 (2011), 2260-2263.
60. K. Halverson, P.E. Fraser, D.A. Kirschner and P.T. Lansbury, Propagating structure of Alzheimer’s b-amyloid(10-35) is parallel b-sheet with residues in exact register, Biochemistry 29 (1990), 2639-2644.
61. P.I. Haris and F. Severcan, FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media, J. Mol. Catal. B: Enzym. 7 (1999), 207-221.
62. D. Helm, H. Labischinski, G. Schallehn and D. Naumann, Classification and identification of bacteria by Fouriertransform infrared spectroscopy, J. Gen. Microbiol. 137 (1991), 69-79.
63. P. Heraud, S. Caine, N. Campanale, T. Karnezis, D. McNaughton, B.R. Wood, M.J. Tobin and C.A. Bernard, Early detection of the chemical changes occurring during the induction and prevention of autoimmune-mediated demyelination detected by FT-IR imaging, Neuroimage 49 (2010), 1180-1189.
64. J. Herz, F. Zipp and V. Siffrin, Neurodegeneration in autoimmune CNS inflammation, Exp. Neurol. 225 (2010), 9-17.
65. Z. Hongyan, P. Xiao, W. Lingyan, L. Bo, Q. Zeming and W. Yuyin, Synchrotron FTIR microspectroscopy study of the striatum in 6-hydroxydopamine rat model of Parkinson’s, Spectrosc. Int. J. 27 (2012), 229-238.
66. M.Z. Ibrahim, M.J. Nasse, M. Rak, C. Hirschmugl, M.R. Del Bigio, B.C. Albensi and K.M. Gough, Biochemical labelfree tissue imaging with subcellular-resolution synchrotron FTIR with focal plane array detector, Neuroimage 60 (2012), 376-383.
67. A. Itkin, V. Dupres, Y.F. Dufrêne, B. Bechinger, J.-M. Ruysschaert and V. Raussens, Calcium ions promote formation of amyloid b peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer’s disease, PLoS One 6 (2011), e18250.
68. N. Jamin, P. Dumas, J. Moncuit, W.H. Fridman, J.L. Teillaud, G.L. Carr and G.P. Williams, Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry, Proc. Natl. Acad. Sci. USA 95 (1998), 4837.
69. N. Jamin, L. Miller, J. Moncuit, W. Fridman, H. Dumas and P. Teillaud, Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells, Biopolymers (Biospectrosc.) 72 (2003), 366-373.
70. S.D. Johnston, Thermotropic behaviour of myelin from multiple sclerosis affected brain, Thermochim. Acta 293 (1997), 129-135.
71. C. Jung, Insight into protein structure and protein-ligand recognition by Fourier transform infrared spectroscopy, J. Mol. Recognit. 13 (2000), 325-351.
72. P. Juszczyk, A.S. Kołodziejczyk, Z. Grzonka and J. Pept, FTIR spectroscopic studies on aggregation process of the β-amyloid 11-28 fragment and its variants, Science 15 (2009), 23-29.
73. J.K. Kauppinen, D.J. Moffatt, H.H. Mantsch and D.G. Cameron, Fourier self-deconvolution: a method for resolving intrinsically overlapped bands, Appl. Spectrosc. 35 (1981), 271-276.
74. J. Kneipp, M. Beekes, P. Lasch and D. Naumann, Molecular changes of preclinical scrapie can be detected by infrared spectroscopy, J. Neurosci. 22 (2002), 2989-2997.
75. J. Kneipp, P. Lasch, E. Baldauf, M. Beekes and D. Naumann, Detection of pathological molecular alterations in scrapieinfected hamster brain by Fourier transform infrared (FT-IR) spectroscopy, Biochim. Biophys. Acta 1501 (2000), 189-199.
76. J. Kneipp, L.M. Miller, M. Joncic, M. Kittel, P. Lasch, M. Beekes and D. Naumann, In situ identification of protein structural changes in prion-infected tissue, Biochim. Biophys. Acta 1639 (2003), 152-158.
77. H. Komatsu, L. Liu, I.V. Murray and P.H. Axelsen, A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy, Biochim. Biophys. Acta 1768 (2007), 1913-1922.
78. A. Kretlow, Q. Wang, M. Beekes, D. Naumann and L.M. Miller, Changes in protein structure and distribution observed at pre-clinical stages of scrapie pathogenesis, Biochim. Biophys. Acta 1782 (2008), 559-565.
79. S. Krimm and J. Bandekar, Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins, J. Adv. Prot. Chem. 36 (1986), 181-364.
80. T. Kuhlmann, G. Lingfeld, A. Bitsch, J. Schuchardt and W. Bruck, Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time, Brain 125 (2002), 2202-2212.
81. A. Kuzyk, M. Kastyak, V. Agrawal, M. Gallant, G. Sivakumar, M. Rak, M.R.D. Bigio, D. Westaway, R. Julian and K.M. Gough, Association between amyloid plaque, lipid, and creatine in hippocampus of TgCRND8 mouse model for Alzheimer disease, J. Biol. Chem. 285 (2010), 31202-31207.
82. O.P. Lamba, D. Borchman and W.H. Garner, Spectral characterization of lipid peroxidation in rabbit lens membranes induced by hydrogen peroxide in the presence of Fe21/Fe31 cations: a sitespecific catalyzed oxidation, Free Rad. Biol. Med. 16 (1994), 591-601.
83. P. Lasch, M. Beekes, J. Schmitt and D. Naumann, Detection of preclinical scrapie from serum by infrared spectroscopy and chemometrics, Anal. Bioanal. Chem. 387 (2007), 1791-1800.
84. P. Lasch, W. Haensch, E.N. Lewis, L.H. Kidder and D. Naumann, Characterization of colorectal adenocarcinoma sections by spatially resolved FT-IR microspectroscopy, Appl. Spectrosc. 56 (2002), 1-9.
85. H. Lassmann, Cellular damage and repair in multiple sclerosis, in: Myelin Biology and Disorders, R.A. Lazzarini et al., eds, Vol. 2, Elsevier Academic Press, San Diego, CA, 2004, pp. 733-762.
86. H. Lassmann, Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models, Exp. Neurol. 225 (2010), 2-8.
87. A.C. Leskovjan, A. Kretlow and L.M. Miller, Fourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer’s disease, Anal. Chem. 82 (2010), 2711-2716.
88. A.C. Leskovjan, A. Lanzirotti and L.M. Miller, Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer’s disease, NeuroImage 47 (2009), 1215-1220.
89. I.W. Levin and R. Bhargava, Fourier transform infrared vibrational spectroscopic imaging: integrating microscopy and molecular recognition, Ann. Rev. Phys. Chem. 56 (2005), 429-474.
90. S.M. LeVine and D.L. Wetzel, Chemical analysis of multiple sclerosis lesions by FT-IR microspectroscopy, Free Rad. Biol. Med. 25 (1998), 33-41.
91. S.M. LeVine, D.L. Wetzel and A.J. Eilert, Neuropathology of twitcher mice: examination by histochemistry, immunohistochemistry, lectin histochemistry and Fourier transform infrared microspectroscopy, Int. J. Dev. Neurosci. 12 (1994), 275-288.
92. R.N.A.H. Lewis and R.N. McEkhaney, Fourier transform infrared spectroscopy in the study of lipid phase transitions in model and biological membranes: practical considerations, Methods Mol. Biol. 400 (2007), 207-226.
93. R.N.A.H. Lewis and R.N. Mcelhaney, Fourier transform infrared spectroscopy in the study of hydrated lipids and lipid bilayer membranes, in: Infrared Spectroscopy of Biomolecules, H.H. Mantsch and D. Chapman, eds, Wiley-Liss, New York, 1996, pp. 159-202.
94. F.H. Lewy and H. Handb, Dementia with Lewy bodies, Neurol. 3 (1912), 920-933.
95. Q.B Li, X.J. Sun, Y.Z. Xu, L.M. Yang, Y.F. Zhang, S.F. Weng, J.S. Shi and J.G. Wu, Diagnosis of gastric inflammation and malignancy in endoscopic biopsies based on Fourier transform infrared spectroscopy, Clin. Chem. 51 (2005), 346-350.
96. K.-Z. Liu, R. Bose and H.H. Mantsch, Infrared spectroscopic study of diabetic platelets, Vibr. Spectrosc. 860 (2002), 1-6.
97. H. Mantsch and M. Jackson, Molecular spectroscopy in biodiagnostics (from Hippocrates to Herschel and beyond), J. Mol. Struct. 347 (1995), 187-206.
98. A. Marcelli, A. Cricenti, W. Kwiatek and C. Petibois, Biological applications of synchrotron radiation infrared spectromicroscopy, Biotechnol. Adv. 30 (2012), 1390-1404.
99. J. Miklossy, A. Kis, A. Radenovic, L. Miller, L. Forro, R. Martins, K. Reiss, N. Darbinian, P. Darekar, L. Mihaly and K. Khalili, Beta-amyloid deposition and Alzheimer’s type changes induced by Borrelia spirochetes, Neurobiol. Aging 27 (2006), 228-236.
100. L.M. Miller and P. Dumas, Chemical imaging of biological tissue with synchrotron infrared light, Biochim. Biophys. Acta 1758 (2006), 846-857.
101. L.M. Miller, Q. Wang, T.P. Telivala, R. Smith, A. Lanzirotti and J. Miklossy, Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease, J. Struct. Biol. 155 (2006), 30-37.
102. Z. Movasaghi, S. Rehman and I. Rehman, Fourier transform infrared (FTIR) spectroscopy of biological tissues, Appl. Spectrosc. Rev. 43 (2008), 134-179.
103. D. Naumann, FT-Infrared and FT-Raman Spectroscopy in Biomedical Research: Infrared and Raman Spectroscopy of Biological Materials, Marcel Dekker, New York, 2001.
104. D. Naumann, D. Helm and H. Labischinski, Microbiological characterization by FTIR spectroscopy, Nature 351 (1991), 81-82.
105. E. Norrby, Prions and protein-folding diseases, J. Intern. Med. 270 (2011), 1-14.
106. N. Ozek, Y. Sara and R. Onur, Low dose simvastatin induces compositional, structural and dynamic changes in rat skeletal extensor digitorum longus muscle tissue, Biosci. Rep. 30 (2010), 41-50.
107. N.S. Ozek, S. Tuna and A.E. Erson-Bensan, Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy, Analyst 135 (2010), 3094-3102.
108. C. Petibois and G. Déléris, Evidence that erythrocytes are highly susceptible to exercise oxidative stress: FT-IR spectrometric studies at the molecular level, Cell Biol. Int. 29 (2005), 709-716.
109. C. Petibois and G. Déléris, Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathology, Trends Biotechnol. 24 (2006), 455-462.
110. C. Petibois, C.M. Guidi, M. Piccinini, M. Moenner and A. Marcelli, Synchrotron radiation FTIR imaging in minutes: a first step towards real time cell imaging, Anal. Bioanal. Chem. 397 (2010), 2123-2129.
111. P. Pisani, D.M. Parkin, F. Bray and J. Ferlay, Estimates of the worldwide mortality from twenty-five major cancers in 1990. Implications for prevention, and projections of future burden, Int. J. Cancer 83 (1999), 18.
112. S.B. Prusiner, Prion diseases and the BSE crisis, Science 278 (1997), 245-251.
113. M. Rak, Synchrotron infrared microspectroscopy of biological tissues: brain tissue from TgCRND8 Alzheimer’s disease mice and developing scar tissue in rats, PhD thesis, University of Manitoba, Winnipeg, Canada, 2007.
114. M. Rango, M. Canesi, I. Ghione, M. Farabola, A. Righini, N. Bresolin, A. Antonini and G. Pezzoli, Parkinson’s disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1-H MRS study, Neurotoxicology 27 (2006), 164-167.
115. P. Ray, R. Ray, C.A. Broomfield and J.D. Berman, Inhibition of bioenergetics alters intracellular calcium, membrane composition and fluidity in a neuronal cell line, Neurochem. Res. 19 (1994), 57-63.
116. R.J. Reiter, B. Poeggeler, D.X. Tan, L.D. Chen, L.C. Manchester and J.M. Guerrero, Antioxidant capacity of melatonin: a novel action not requiring a receptor, Neuroendocrinol. 15 (1993), 103-116.
117. J. Ruiz-Sanz, J. Ruiz-Cabello, P.L. Mateo and M. Cortijo, The thermal transition in crude myelin proteolipid has a lipid rather than protein origin, Eur. Biophys. J. 21 (1992), 71-76.
118. P.S. Sastry, Lipids of nervous tissue: composition and metabolism, Progress Lipid Res. 24 (1985), 69-176.
119. J. Schmitt and H.C. Flemming, FTIR-spectroscopy in microbial and material analysis, Int. Biodeteriorat. Biodegrad. 41 (1998), 1-11.
120. J.M. Schubert, A.I. Mazur, B. Bird, M. Miljkovic and M. Diem, Single point vs. mapping approach for spectral cytopathology (SCP), J. Biophotonics 3 (2010), 588-596.
121. F. Severcan, G. Gorgulu and S.T. Gorgulu, Rapid monitoring of diabetes-induced lipid peroxidation by Fourier transform infrared spectroscopy: evidence from rat liver microsomal membranes, Anal. Biochem. 339 (2005), 36-40.
122. S. Shiek, J. Ahmeda, W. Santosh, S. Kumar and T.H. Thanka, Neural network algorithm for the early detection of Parkinson’s disease from blood plasma by FTIR micro-spectroscopy, Vibr. Spectrosc. 53 (2010), 181-188.
123. C. Signorini, M. Ferrali, L. Ciccoli, L. Sugherini, A. Magnani and M. Comporti, Iron release, membrane protein oxidation and erythrocyte ageing, FEBS Let. 362 (1995), 165-170.
124. R.M. Silverstein, G.C. Bassler and T.C. Morrill, Spectrometric Identification of Organic Compounds, Wiley, New York, 1991.
125. K.J. Smith and H. Lassmann, The role of nitric oxide in multiple sclerosis, Lancet Neurol. 1 (2002), 232-241.
126. G. Steiner, A. Shaw, L.P. Choo-Smith, M.H. Abuid, G. Schackert, S. Sobottka, W. Steller, R. Salzer and H.H. Mantsch, Distinguishing and grading human gliomas by IR spectroscopy, Biopolymers 72 (2003), 464-471.
127. D.M. Stitt, Z. Marzena, K. Ibrahim, C.R. Liao, J. Morrison, B.C. Albensi and K.M. Gough, Tissue acquisition and storage associated oxidation considerations for FTIR microspectroscopic imaging of polyunsaturated fatty acids, Vib. Spectr. 60 (2012), 16-22.
128. B. Stuart, Biological Applications of Infrared Spectroscopy, Wiley, Chichester, 1997.
129. W.K. Surewicz, M. Moscarello and H.H. Mantsch, Fourier transform infrared spectroscopic investigation of the interaction between myelin basic protein and dimyristoylphosphatidylglycerol bilayers, Biochemistry 26 (1987), 3881-3886.
130. M. Szczerbowska-Boruchowska, P. Dumas and M.Z. Kastyak, Biomolecular investigation of human substantia nigra in Parkinson’s disease by synchrotron radiation Fourier transform infrared microspectroscopy, Arch. Biochem. Biophys. 459 (2007), 241-248.
131. E. Taillandier and J. Liquier, Infrared spectroscopy of DNA, Methods Enzymol. 211 (1992), 307-335.
132. A. Thomzig, S. Spassov, M. Friedrich, D. Naumann and M. Beekes, Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein, JBC 279 (2004), 33847-33854.
133. N. Toyran, F. Severcan and M. Severcan, Investigation of diabetes-induced effect on apex of rat heart myocardium by using cluster analysis and neural network approach: an FTIR study, Spectrosc. Int. J. 21 (2007), 269-278.
134. N. Toyran, F. Zorlu, G. Donmez, K. Oge and F. Severcan, Chronic hypoperfusion alters the content and structure of proteins and lipids of rat brain homogenates: a Fourier transform infrared spectroscopy study, Eur. Biophys. J. 33 (2004), 549-554.
135. S. Turker, M. Severcan, G. Ilbay and F. Severcan, Investigation of the effects of different epileptic activities on cell membrane proteins reveals diagnostic information, Amino Acid 41 (2011), 28.
136. S. Turker, M. Severcan, S. Komsuoğlu and F. Severcan, The structural investigation of protective role of antiepileptic vigabatrin in epilepsy treatment by FTIR spectroscopy and neural networks, Mol. Biol. Cell 22 (2011), 691.
137. S.G. Turker, Molecular investigation of PTZ-induced epileptic activities in rat brain cell membranes and the effects of vigabatrin, PhD thesis, Middle East Technical University, Ankara, Turkey, 2007.
138. N.P. Ulrih, C.H. Barry and A.L. Fink, Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties, Biochim. Biophys. Acta 1782 (2008), 581-585.
139. V.N. Uversky, J. Li, P. Souillac, I.S. Millett, S. Doniach, R. Jakes, M. Goedert and A.L. Fink, Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins, J. Biol. Chem. 277 (2002), 11970-11978.
140. Q. Wang, A. Kretlow, M. Beekes, D. Naumann and L. Miller, In situ characterization of prion protein structure and metal accumulation in scrapie-infected cells by synchrotron infrared and X-ray imaging, Vib. Spectrosc. 38 (2005), 61-69.
141. D.L. Wetzel and S.M. LeVine, Imaging molecular chemistry with infrared microscopy, Science 285 (1999), 1224-1225.
142. H. Woo, N. Park, S. Gwon, R. Arumugam and T.V. Jo, Alzheimer’s disease and notch signaling, Biochem. Biophys. Res. Commun. 390 (2009), 1093-1097.
143. G. Yamin, L.A. Munishkina, M.A. Karymov, Y.L. Lyubchenko, V.N. Uversky and A.L. Fink, Forcing nonamyloidogenic beta-synuclein to fibrillate, Biochemistry 44 (2005), 9096-90107.
144. A.L. Zozulya and H. Wiendl, The role of regulatory T cells in multiple sclerosis, Nat. Clin. Pract. Neurol. 4 (2008), 384-398.